Sustained drug retention after paclitaxel-coated balloon angioplasty for superficial femoral artery disease: Follow-up intravascular imaging

A 63 year-old woman with claudication underwent endovascular therapy for diffuse stenosis of the right superficial femoral artery in our hospital. We performed paclitaxel-coated balloon angioplasty using the IN.PACT™ Admiral™ and achieved acceptable results. After 42 days, we performed follow-up opt...

Full description

Bibliographic Details
Main Authors: Norihiro Kobayashi, Keisuke Hirano, Masahiro Yamawaki, Motoharu Araki, Tsuyoshi Sakai, Yasunari Sakamoto, Shinsuke Mori, Masakazu Tsutsumi, Masahiro Nauchi, Naohiko Sahara, Yohsuke Honda, Kenji Makino, Shigemitsu Shirai, Masafumi Mizusawa, Yuta Sugizaki, Takahide Nakano, Tomoya Fukagawa, Toshihiko Kishida, Yuki Kozai, Yusuke Setonaga, Shutaro Goda, Yoshiaki Ito
Format: Article
Language:English
Published: SAGE Publishing 2020-02-01
Series:SAGE Open Medical Case Reports
Online Access:https://doi.org/10.1177/2050313X20907825
_version_ 1819000995856777216
author Norihiro Kobayashi
Keisuke Hirano
Masahiro Yamawaki
Motoharu Araki
Tsuyoshi Sakai
Yasunari Sakamoto
Shinsuke Mori
Masakazu Tsutsumi
Masahiro Nauchi
Naohiko Sahara
Yohsuke Honda
Kenji Makino
Shigemitsu Shirai
Masafumi Mizusawa
Yuta Sugizaki
Takahide Nakano
Tomoya Fukagawa
Toshihiko Kishida
Yuki Kozai
Yusuke Setonaga
Shutaro Goda
Yoshiaki Ito
author_facet Norihiro Kobayashi
Keisuke Hirano
Masahiro Yamawaki
Motoharu Araki
Tsuyoshi Sakai
Yasunari Sakamoto
Shinsuke Mori
Masakazu Tsutsumi
Masahiro Nauchi
Naohiko Sahara
Yohsuke Honda
Kenji Makino
Shigemitsu Shirai
Masafumi Mizusawa
Yuta Sugizaki
Takahide Nakano
Tomoya Fukagawa
Toshihiko Kishida
Yuki Kozai
Yusuke Setonaga
Shutaro Goda
Yoshiaki Ito
author_sort Norihiro Kobayashi
collection DOAJ
description A 63 year-old woman with claudication underwent endovascular therapy for diffuse stenosis of the right superficial femoral artery in our hospital. We performed paclitaxel-coated balloon angioplasty using the IN.PACT™ Admiral™ and achieved acceptable results. After 42 days, we performed follow-up optical frequency domain imaging for the right superficial femoral artery lesion treated with paclitaxel-coated balloon and observed several high-intensity regions with attenuation on the lumen surface. Sustained drug availability is a notable characteristic of paclitaxel-coated balloon. To the best of our knowledge, this is the first report on the visualization of sustained drug retention on the lumen surface using follow-up optical frequency domain imaging after paclitaxel-coated balloon angioplasty in a human patient with superficial femoral artery disease.
first_indexed 2024-12-20T22:42:11Z
format Article
id doaj.art-d6dbf6c78aec4b03a6cc92bf0b11c7ab
institution Directory Open Access Journal
issn 2050-313X
language English
last_indexed 2024-12-20T22:42:11Z
publishDate 2020-02-01
publisher SAGE Publishing
record_format Article
series SAGE Open Medical Case Reports
spelling doaj.art-d6dbf6c78aec4b03a6cc92bf0b11c7ab2022-12-21T19:24:28ZengSAGE PublishingSAGE Open Medical Case Reports2050-313X2020-02-01810.1177/2050313X20907825Sustained drug retention after paclitaxel-coated balloon angioplasty for superficial femoral artery disease: Follow-up intravascular imagingNorihiro KobayashiKeisuke HiranoMasahiro YamawakiMotoharu ArakiTsuyoshi SakaiYasunari SakamotoShinsuke MoriMasakazu TsutsumiMasahiro NauchiNaohiko SaharaYohsuke HondaKenji MakinoShigemitsu ShiraiMasafumi MizusawaYuta SugizakiTakahide NakanoTomoya FukagawaToshihiko KishidaYuki KozaiYusuke SetonagaShutaro GodaYoshiaki ItoA 63 year-old woman with claudication underwent endovascular therapy for diffuse stenosis of the right superficial femoral artery in our hospital. We performed paclitaxel-coated balloon angioplasty using the IN.PACT™ Admiral™ and achieved acceptable results. After 42 days, we performed follow-up optical frequency domain imaging for the right superficial femoral artery lesion treated with paclitaxel-coated balloon and observed several high-intensity regions with attenuation on the lumen surface. Sustained drug availability is a notable characteristic of paclitaxel-coated balloon. To the best of our knowledge, this is the first report on the visualization of sustained drug retention on the lumen surface using follow-up optical frequency domain imaging after paclitaxel-coated balloon angioplasty in a human patient with superficial femoral artery disease.https://doi.org/10.1177/2050313X20907825
spellingShingle Norihiro Kobayashi
Keisuke Hirano
Masahiro Yamawaki
Motoharu Araki
Tsuyoshi Sakai
Yasunari Sakamoto
Shinsuke Mori
Masakazu Tsutsumi
Masahiro Nauchi
Naohiko Sahara
Yohsuke Honda
Kenji Makino
Shigemitsu Shirai
Masafumi Mizusawa
Yuta Sugizaki
Takahide Nakano
Tomoya Fukagawa
Toshihiko Kishida
Yuki Kozai
Yusuke Setonaga
Shutaro Goda
Yoshiaki Ito
Sustained drug retention after paclitaxel-coated balloon angioplasty for superficial femoral artery disease: Follow-up intravascular imaging
SAGE Open Medical Case Reports
title Sustained drug retention after paclitaxel-coated balloon angioplasty for superficial femoral artery disease: Follow-up intravascular imaging
title_full Sustained drug retention after paclitaxel-coated balloon angioplasty for superficial femoral artery disease: Follow-up intravascular imaging
title_fullStr Sustained drug retention after paclitaxel-coated balloon angioplasty for superficial femoral artery disease: Follow-up intravascular imaging
title_full_unstemmed Sustained drug retention after paclitaxel-coated balloon angioplasty for superficial femoral artery disease: Follow-up intravascular imaging
title_short Sustained drug retention after paclitaxel-coated balloon angioplasty for superficial femoral artery disease: Follow-up intravascular imaging
title_sort sustained drug retention after paclitaxel coated balloon angioplasty for superficial femoral artery disease follow up intravascular imaging
url https://doi.org/10.1177/2050313X20907825
work_keys_str_mv AT norihirokobayashi sustaineddrugretentionafterpaclitaxelcoatedballoonangioplastyforsuperficialfemoralarterydiseasefollowupintravascularimaging
AT keisukehirano sustaineddrugretentionafterpaclitaxelcoatedballoonangioplastyforsuperficialfemoralarterydiseasefollowupintravascularimaging
AT masahiroyamawaki sustaineddrugretentionafterpaclitaxelcoatedballoonangioplastyforsuperficialfemoralarterydiseasefollowupintravascularimaging
AT motoharuaraki sustaineddrugretentionafterpaclitaxelcoatedballoonangioplastyforsuperficialfemoralarterydiseasefollowupintravascularimaging
AT tsuyoshisakai sustaineddrugretentionafterpaclitaxelcoatedballoonangioplastyforsuperficialfemoralarterydiseasefollowupintravascularimaging
AT yasunarisakamoto sustaineddrugretentionafterpaclitaxelcoatedballoonangioplastyforsuperficialfemoralarterydiseasefollowupintravascularimaging
AT shinsukemori sustaineddrugretentionafterpaclitaxelcoatedballoonangioplastyforsuperficialfemoralarterydiseasefollowupintravascularimaging
AT masakazutsutsumi sustaineddrugretentionafterpaclitaxelcoatedballoonangioplastyforsuperficialfemoralarterydiseasefollowupintravascularimaging
AT masahironauchi sustaineddrugretentionafterpaclitaxelcoatedballoonangioplastyforsuperficialfemoralarterydiseasefollowupintravascularimaging
AT naohikosahara sustaineddrugretentionafterpaclitaxelcoatedballoonangioplastyforsuperficialfemoralarterydiseasefollowupintravascularimaging
AT yohsukehonda sustaineddrugretentionafterpaclitaxelcoatedballoonangioplastyforsuperficialfemoralarterydiseasefollowupintravascularimaging
AT kenjimakino sustaineddrugretentionafterpaclitaxelcoatedballoonangioplastyforsuperficialfemoralarterydiseasefollowupintravascularimaging
AT shigemitsushirai sustaineddrugretentionafterpaclitaxelcoatedballoonangioplastyforsuperficialfemoralarterydiseasefollowupintravascularimaging
AT masafumimizusawa sustaineddrugretentionafterpaclitaxelcoatedballoonangioplastyforsuperficialfemoralarterydiseasefollowupintravascularimaging
AT yutasugizaki sustaineddrugretentionafterpaclitaxelcoatedballoonangioplastyforsuperficialfemoralarterydiseasefollowupintravascularimaging
AT takahidenakano sustaineddrugretentionafterpaclitaxelcoatedballoonangioplastyforsuperficialfemoralarterydiseasefollowupintravascularimaging
AT tomoyafukagawa sustaineddrugretentionafterpaclitaxelcoatedballoonangioplastyforsuperficialfemoralarterydiseasefollowupintravascularimaging
AT toshihikokishida sustaineddrugretentionafterpaclitaxelcoatedballoonangioplastyforsuperficialfemoralarterydiseasefollowupintravascularimaging
AT yukikozai sustaineddrugretentionafterpaclitaxelcoatedballoonangioplastyforsuperficialfemoralarterydiseasefollowupintravascularimaging
AT yusukesetonaga sustaineddrugretentionafterpaclitaxelcoatedballoonangioplastyforsuperficialfemoralarterydiseasefollowupintravascularimaging
AT shutarogoda sustaineddrugretentionafterpaclitaxelcoatedballoonangioplastyforsuperficialfemoralarterydiseasefollowupintravascularimaging
AT yoshiakiito sustaineddrugretentionafterpaclitaxelcoatedballoonangioplastyforsuperficialfemoralarterydiseasefollowupintravascularimaging